ABBOTT LABORATORIES Accumulated OCI 2007-2026 | ABT
Beta
What is accumulated oci?
Accumulated other comprehensive income (OCI) includes unrealized gains and losses from foreign currency translation, available-for-sale securities, and pension adjustments.
What is ABBOTT LABORATORIES's current accumulated oci?
ABBOTT LABORATORIES (ABT) annual accumulated oci for 2025 was $-6.00B, a 24.10% increase from 2024. ABBOTT LABORATORIES accumulated oci for the quarter ending March 31, 2026 was $-6.31B.
What was ABBOTT LABORATORIES's accumulated oci in 2024?
ABBOTT LABORATORIES annual accumulated oci for 2024 was $-7.91B, a 0.85% decline from 2023.
What was ABBOTT LABORATORIES's accumulated oci in 2023?
ABBOTT LABORATORIES annual accumulated oci for 2023 was $-7.84B, a 2.63% increase from 2022.
Accumulated OCI History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-8.95B
→
FY2025
$-6.00B
07080910111213141516171819202122232425
5 years selected
Accumulated OCI History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-6.00B | +24.1% | 10-K |
| FY2024 | $-7.91B | -0.9% | 10-K |
| FY2023 | $-7.84B | +2.6% | 10-K |
| FY2022 | $-8.05B | +3.9% | 10-K |
| FY2021 | $-8.37B | +6.4% | 10-K |
| FY2020 | $-8.95B | -5.7% | 10-K |
| FY2019 | $-8.46B | -11.6% | 10-K |
| FY2018 | $-7.59B | -25.1% | 10-K |
| FY2017 | $-6.06B | +16.5% | 10-K |
| FY2016 | $-7.26B | -9.1% | 10-K |
| FY2015 | $-6.66B | -31.8% | 10-K |
| FY2014 | $-5.05B | -151.1% | 10-K |
| FY2013 | $-2.01B | +44.0% | 10-K |
| FY2012 | $-3.59B | -1795.3% | 10-K |
| FY2011 | $212.0M | +115.5% | 10-K |
| FY2010 | $-1.37B | -260.1% | 10-K |
| FY2009 | $854.1M | +173.4% | 10-K |
| FY2008 | $-1.16B | -155.9% | 10-K |
| FY2007 | $2.08B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →